Background: Stakeholders are people with an interest in a topic. Internationally, stakeholder involvement in palliative care research and health technology assessment requires development. Stakeholder involvement adds value throughout research (from prioritising topics to disseminating findings). Philosophies and understandings about the best ways to involve stakeholders in research differ internationally. Stakeholder involvement took place in seven countries (England, Germany, Italy, Lithuania, the Netherlands, Norway and Poland). Findings informed a project that developed concepts and methods for health technology assessment and applied these to evaluate models of palliative care service delivery. Aims: To report on stakeholder involvement in the INTEGRATE-HTA project and how issues identified informed project development. Design: Using stakeholder consultation or a qualitative research design, as appropriate locally, stakeholders in seven countries acted as 'advisors' to aid researchers' decision making. Thematic analysis was used to identify key issues across countries. Setting/participants: A total of 132 stakeholders (82 professionals and 50 'lay' people) aged ⩾18 participated in individual face-toface or telephone interviews, consultation meetings or focus groups. Results: Different stakeholder involvement methods were used successfully to identify key issues in palliative care. A total of 23 issues common to three or more countries informed decisions about the intervention and comparator of interest, sub questions and specific assessments within the health technology assessment. Conclusion: Stakeholders, including patients and families undergoing palliative care, can inform project decision making using various involvement methods according to the local context. Researchers should consider local understandings about stakeholder involvement as views of appropriate and feasible methods vary. Methods for stakeholder involvement, especially consultation, need further development.
What is already known about the topic?
• • Internationally, stakeholder (i.e. lay people and professionals with an interest in the topic) involvement in research and health technology assessment (HTA) is advocated. Stakeholder involvement has the potential to ensure key shared priorities are addressed and research findings translated into practice. • • The philosophy and views about the best approaches for stakeholder involvement differ across Europe. Stakeholder consultation is seen as one of the most appropriate approaches to involvement in some countries. However, qualitative research is viewed as the most appropriate method of stakeholder involvement in other European countries. • • Few reports exist about stakeholder involvement in palliative care and the ways this informs decision making in HTA.
What this paper adds?
• • This paper demonstrates that it is possible to involve lay (e.g. patients/ex-patients, family carers/ex-carers, family members and members of public organisations or groups) and professional (e.g. service commissioners, health and social care professionals/academics working in palliative care) stakeholders in HTA. Indeed, stakeholders, even patients and families undergoing palliative care, can be involved in HTA in a range of ways according to local contexts. • • Several approaches to stakeholder involvement in palliative care research are shown to be feasible and effective ways to identify stakeholder priorities. • • Despite the use of different methods of stakeholder involvement, stakeholders highlight a number of issues in palliative care that are 'common' across countries. The researchers used the issues raised to inform decision making for project development. Notably, the issues raised informed the focus of the main HTA question and sub questions used in the assessment of specific aspects.
Implications for practice, theory or policy
• • Different methods of stakeholder involvement may be required for different palliative care stakeholder groups in different countries.
Introduction
Stakeholder involvement aims to gain the views and perspectives of stakeholders to inform research and health technology assessment (HTA). Stakeholders include professionals (e.g. service commissioners, professionals and academics) and lay people (e.g. service users and their family carers). Internationally, the need for stakeholder involvement in palliative care research has been recognised. 1 Although published examples of lay stakeholder involvement in palliative care research exist, 2 several barriers including a lack of time, available funds, clarity and specificity about the role of public involvement in research 2 need to be overcome. Stakeholder involvement, including patient involvement, is established in HTA as many groups have a legitimate interest in the outcome of HTA projects. 3 HTA research informs health policy decision making to ensure best value for money. 4 HTA uses a multidisciplinary approach to systematically and transparently assess the cost and clinical effectiveness, safety, organisational, ethical, legal and social issues of health technologies (e.g. medicines, devices, procedures and health care services). 4 There is increasing recognition of the need for HTA to assess complex health technologies 5 which are imperative in dealing with the rise in numbers of people with chronic diseases. Incrementally changing, context-dependent palliative care services are a good example of a complex technology. 6 However, there is a need to determine which models of palliative care service provision are most effective to inform future health policy and service decision making. 7 This is especially important as models of palliative care service provision across Europe are developing in various ways (reflecting the different cultures, religious beliefs and legal frameworks that exist). 8 Palliative care research in the context of HTA is still in its infancy. Hence, while knowledge and experience of stakeholder involvement is growing in a number of fields, 2,9 further guidance relating specifically to stakeholder involvement in palliative care research and HTA is needed. This is particularly important as the usefulness and utilisation of HTA depend on stakeholder involvement. 3 Despite recognition that stakeholder involvement is important in HTA, some hesitancy exists about how much influence stakeholders should have on scientific processes. 3 Furthermore, the extent and methods used for stakeholder involvement varies according to national and regional needs and traditions. 3 Indeed, the philosophy and understandings about the most appropriate ways to involve stakeholders (especially patients and the public) in research differs across Europe. For example, INVOLVE, a UK national advisory group was set up to support public involvement (i.e. patients, carers and those using health and social services) in National Health Service (NHS), public health and social care research, 10 although such mechanisms are not evident elsewhere in Europe. INVOLVE differentiate between public involvement, participation and engagement in research (see Box 1) . INVOLVE suggest stakeholder consultation (i.e. asking people their views) is one approach to involvement that can inform decision making in research. 10 However, qualitative research is advocated as the best approach to stakeholder involvement in several countries across Europe, although no specific methodology is recommended. An opportunity to involve palliative care stakeholders presented itself in the context of a large European project (INTEGRATE-HTA) (see http://www.integrate-hta.eu/). The INTEGRATE-HTA project developed concepts and methods for the integrated assessment of complex technologies as policy-makers need better tools to support their decision making regarding complex health technologies. 11 To demonstrate their feasibility and value, concepts and methods developed in the project were applied in a case study using models of palliative care service delivery as an example of a complex technology. As palliative care provision differs throughout Europe, 8 the case study was undertaken in England for pragmatic reasons. At the outset of the INTEGRATE-HTA project, we wanted to identify key issues in palliative care in all participating countries to ensure that the project findings may have relevance to more than one country. Hence, we collected stakeholders' perspectives about key issues and topics of importance for palliative care as one way of involving stakeholders and influencing researchers' decision making throughout the project. A separate paper is being developed to report on the extensive stakeholder involvement that occurred throughout the project.
Aim
This article reports on stakeholder involvement in seven European countries as part of the INTEGRATE-HTA project.
Methods

Design and settings
Lay and professional palliative care stakeholders in seven European countries acted as 'advisors' to inform project development from an early stage. As 'advisors', stakeholders provided information or data that informed researchers' decision making in the project. An experienced HTA researcher or palliative care clinician was appointed to be a local co-ordinator in each country. Local co-ordinators were given a guide to assist in establishing some consistency in planning stakeholder involvement, including example documentation (e.g. information sheets, consent forms). Additional guidance was given by the wider project team based on their knowledge of methodologically and contextually appropriate methods for each country. Methodological details are reported in Tables 1-3. As stakeholder involvement to assist project development in HTA is novel 12 and palliative care is a complex and culturally sensitive topic, 8 a local co-ordinator conducted stakeholder meetings in each country. The local co-ordinator was a member of the research team or their known associates, some of whom were experienced in palliative care research and others were HTA researchers. The local co-ordinator ensured that adequate support was available for stakeholders taking part in the project (e.g. ensuring an additional facilitator was available or allowing relatives to be present in meetings/ interviews in case stakeholders became distressed). The local co-ordinator selected appropriate methods and arranged and/or conducted stakeholder meetings based on what is considered best practice for stakeholder involvement and palliative care in their own country. Across the seven countries, two approaches to stakeholder involvement were used -stakeholder consultation or a qualitative research approach:
1. Stakeholder consultation: Local co-ordinators in England, Norway and Poland adopted the UK's philosophy for lay stakeholder involvement and all stakeholders were consulted as 'research advisors' to inform researchers' decision making in the project. Consultations were guided by the National Institute for Health and Care Excellence (NICE) (2012) methods for developing public health guidance 13 and the INVOLVE (2012) briefing notes for involving the public in research. 2 Information was collected and summarised using the EUnetHTA Core Model ®14 as an overarching framework (see Table 2 ). 2. Qualitative research: A variety of qualitative approaches were used in four countries (Germany, Italy, the Netherlands and Lithuania) according to local tradition and researcher preference about stakeholder involvement. These included nominal group technique 15 and categorical coding procedure following grounded theory methodology by Strauss and Corbin; 16 interactive evaluation and subsequently case reconstruction using constant comparison 17 and thematic analysis 18 (see Table 3 ).
Ethical approval
Ethical approval requirements varied in each country.
Where needed, local co-ordinators ensured that appropriate ethical approval was secured prior to stakeholder involvement. In England, stakeholders were involved as advisors and therefore ethical approval was not required in keeping with the National Research Ethics Service (NRES) and INVOLVE (2009) joint statement. 19 In Lithuania, permission was obtained from the Director of the Hospice and verbal consent was subsequently obtained from participants. In the Netherlands, the ethics committee waived ethics approval for stakeholder discussions. In Poland, ethical approval was obtained for the meeting with family members. Ethical approval was granted from the respective committees in Germany, Italy and all relevant institutions in Norway. In all countries, stakeholders received a letter and information sheet prior to taking part in the project. Oral and written consent was gained in all countries.
Stakeholders
Recognising different types of stakeholder expertise, both professionals and lay people were invited to participate. The aim was to ensure variation in advisors' status and health care settings, thus providing a 'voice' for as many stakeholders as possible. A total of 132 stakeholders (82 professionals and 50 'lay' people) aged 18 and over were recruited across the seven countries (see Table 4 ). Most stakeholders were female (n = 90) and (where known) White Christians.
Working with stakeholders
Researchers in each country, with varying experience of palliative care and of working with stakeholders, undertook work with stakeholders in their native language between May 2013 and June 2014. Where possible, researchers with experience of talking to patients with palliative care needs conducted meetings and interviews. All stakeholders were well enough to take part in the project without any special arrangements being made. However, care was taken not to overtire stakeholders, especially patients and carers. Patients could have relatives or carers present in the meeting/interview if they wished, although none took up this opportunity. Additional staff (i.e. an administrator) attended some meetings to provide support in meetings. Various mechanisms were used to feedback to stakeholders, including sending them a summary of the information they provided for verification of the issues raised and/or feeding back to stakeholders at subsequent meetings (some lay stakeholders participated in bi annual advisory meetings throughout the project in England).
Stakeholder consultation
See Table 1 for more details of methods used in England, Norway and Poland. Palliative care experts identified stakeholders. An adapted version of the EUnetHTA core model ®14 domains (with some example questions for the assessment elements) (see Table 2 ) provided a comprehensive structure that guided individual or small group faceto-face or telephone discussions with all stakeholders. The adaptations involved specifically seeking advice about palliative care when asking about each domain and seeking stakeholder views about heterogeneity and patient preferences. One or two questions were prepared relating to assessment elements for each domain in case a prompt was required (see Table 2 ). However, these questions were usually not required as the domain headings proved sufficient to stimulate 'free-flowing' discussion of key issues across domains. Audio recordings were transcribed and/or notes (all anonymised) were written up after each meeting. Each local co-ordinator undertook analysis to identify key issues within each of the EUnetHTA Core Model ®14 domains.
Qualitative research approach
See Table 3 for more details of methods used in Germany, Italy, the Netherlands and Lithuania, where procedures were undertaken in accordance with the qualitative research methodologies selected. Convenience and purposive sampling strategies were used 20 along with face-toface data collection. In the Netherlands and Italy, individual interviews were completed; the latter were guided by the EUnetHTA Core Model ® . 14 In Germany, individual interviews were used with patients and focus groups with relatives and professionals. In Lithuania, focus groups and one individual interview were conducted with professionals, some of whom were representing patient organisations. Discussions were either audio recorded and/or notes were taken. Audio recordings were transcribed and notes were written up after each meeting. Co-ordinators undertook analysis as appropriate for their qualitative approach. 20 
Synthesising the findings from all stakeholders
There is an absence of evidence-based guidance on synthesising findings across different qualitative and stakeholder consultation paradigms. As the project developed concepts and methods for HTA, we used the EUnetHTA Core Model ®14 domains to structure the findings from stakeholder involvement in an attempt to identify issues that could inform as many HTA assessment aspects and sub questions as possible. Therefore, a table listing the key issues within each of the EUnetHTA Core Model ®14 domains was developed and populated with the results from each of the seven countries. The list of issues was clustered into four broad 'themes' using an approach guided by thematic analysis in qualitative research (see Table 5 ). 20 This approach was intentionally reductive for pragmatic reasons, reflecting the need to produce a coherent synthesis, while recognising that different philosophies underpinned the various approaches used. 21 The COREQ (Consolidated criteria for reporting qualitative research) checklist 22 was used for reporting on qualitative research and the GRIPP (Guidance for Reporting Involvement of Patients and Public) checklist 23 for reporting on patient and public involvement in research.
Findings
Stakeholders identified 23 key issues that were common to three or more countries. These issues were categorised under four themes (see Table 5 ) to identify similarities in findings across different countries. While word limits Table 4 . Background details of the stakeholders involved in each country. Christian -9
Years' experience of palliative care: range (mean) 1-26 years (8.86 (based on 15 responses) All 4 patients had less than 6 months' experience and relatives had Table 5 . Common issues identified by stakeholders across seven countries (England, Germany, Italy, the Netherlands, Norway, Lithuania and Poland).
Countries Common issues identified by stakeholders
Theme 1: knowledge and understanding Information about issues related to the knowledge and understanding of palliative care were clustered within this theme E, G, I, L, Ne, No, P Improve professional's ability to recognise patients with palliative care needs and transition to palliative care E, G, I, L, Ne, No, P Ensure practitioners are adequately trained to deliver palliative care including providing support for generalists providing palliative care E, G, I, L, No, P Improve understanding of the definition and nature of palliative care by professionals, patients and the public/society E, I, L, Ne, P Reduce stigma of death and palliative care in society E, I, L, No, P Develop greater understanding (for professionals, patients and the public) about harms and reduce physical, psychological, social and economic harms for patients (e.g. side effects of treatments/ medicalisation of dying), families (e.g. stress of caring/bereavement/economic problems) and staff (e.g. burnout) E, I, L, P Provide training and support for family carers E, G, I, L, No, P Identify what effectiveness means for palliative care services (QoL, symptom control are the focus for effectiveness) E, L, No Improve patient and carer understanding of ethical issues (e.g. discontinuation of futile treatments) E, G, I
Increase patients', carers' and professionals' understanding of a range of legal issues relating to palliative care (e.g. the right to live or die, euthanasia, safeguarding, capacity, advanced directives, patient's autonomy) E, G, I, L Develop an understanding of how different social and cultural backgrounds of patients and staff influence the provision of palliative care Theme 2: organisational dependent availability and access Information about issues related to the availability and access to palliative care were clustered under this theme E, G, I, L, No, P Increase availability of palliative care -e.g. increase bed numbers and service to all disease types, more patients -elderly MH LD and in a variety of geographical and care settings -e.g. rural areas/ nursing homes/home E, G, I, L, No, P Enhance recognition of palliative care as a speciality E, G, I, L, Ne, No, P Funding of palliative care requires attention (to ensure funding continues or to reduce costs) E, G, I, L, No, P Equity of access to palliative care is a concern due to availability of palliative care, specific professions and eligibility criteria E, G, I, No, P Ensure easy (e.g. out of hours), equitable (e.g. to all groups) and timely (e.g. not restricted only to the last months of life) access to palliative care E, G, I, L, No, P Possible over-treatment (if death seen as a defeat by professionals) or under-treatment (because of failure to identify palliative care needs) E, I, No, P Improve availability of specific disciplines within the palliative care -e.g. dieticians, psychologists, occupational therapists, music therapists E, G, I, P Provide support for family carers post bereavement preclude presenting separate lay and professional findings in this article, lay contributions primarily provided insights into patients' and carers' experiences of services whereas professionals were able to draw on their experiences of service provision to a wide range of clients and situations. We used the issues raised to help identify to identify both an intervention and comparator model of service provision for the main HTA question. We also used the issues raised to inform sub questions for the assessment of specific aspects (e.g. ethical, socio-cultural aspects). Two of the issues raised by stakeholders, the need to increase home care provision and for caregiver training/support, resonated with the findings of a review of review level evidence about models of service provision that had been completed at the same time as the initial stakeholder involvement. (The review was undertaken to assist decision making about intervention and comparator models that could be used to test concepts and methods developed in the project within the palliative care case study).
Insights from the evidence base and stakeholder views of the key issues in palliative care allowed us to select home-based models of palliative care with and without an additional component of informal carer support as the focus for the case study. These models, known as 'reinforced' and 'non-reinforced' models of home care, 24 respectively, provided the intervention and comparator models for the main HTA research question. Reinforced models of home palliative care explicitly address two of the issues raised by stakeholders in several countries (i.e. the need for caregiver training/support and the need to increase home care). The remaining issues helped to sensitise the team to key issues in palliative care, assisted the development of sub questions (e.g. for the socio-cultural aspects which focused on the userprofessional relationship and decision making) and subsequently informed specific assessments (e.g. the ethical assessment) within the HTA.
Discussion
Despite differences in palliative care provision throughout Europe 8 and the use of various locally sensitive consultation methods, stakeholders in seven European countries identified common issues in palliative care. Stakeholders' advice informed the project in several ways, notably enhancing our understanding of palliative care and enabling the team to select 'reinforced' and 'non-reinforced' models of home-based palliative care 24 as the intervention and comparator of interest for the application of the HTA methods developed in the project. Additionally, stakeholder involvement sensitised the team to key issues in palliative care (e.g. the philosophy of palliative care which views the patient and caregiver as a unit of care; patient preferences of home care/death which is reflected in policy initiatives to increase availability of home palliative care/home death across several countries involved in the project). As a result, stakeholder involvement also subsequently informed sub questions and specific assessments within the HTA (e.g. the ethical and socio-cultural assessments).
We learned that both lay and professional stakeholders can contribute much experiential knowledge of palliative care, assisting project development. Involving stakeholders required consideration of their needs for access, support; appropriate project information and questioning in a manner that enhanced their confidence in providing information/data. The methodological, ethical and practical issues for stakeholder involvement in palliative care research vary between countries. There is no recommended approach to stakeholder involvement and, although clear methodologies exist when using qualitative research approaches, this is not the case for stakeholder consultation. Sharma et al. 25 assert, stakeholder perspectives can be viewed as 'colloquial evidence' that provides additional knowledge and has a different role to that of other types of evidence. Hence, as Sharma et al. 25 suggest, this type of knowledge should not be judged in the same way as other evidence because it is not collected in the same rigorous and systematic manner.
While no consensus exists about the best methods of stakeholder consultation, 26 using locally sensitive methods of stakeholder involvement, we ensured that a variety of stakeholder perspectives of palliative care were integrated into the project design. This adds to the body of evidence that stakeholders, including patients and the public, can assist in designing research 4 which changes their roles and relationships with researchers. 27 Given the different stakeholder roles and relationships with researchers, we had to overcome uncertainty about ethical requirements which vary in each country when undertaking stakeholder involvement, especially when using a consultation approach. Furthermore, systematic methods for identifying common topics proved challenging, although similar issues arose across countries.
Despite interest in palliative care among European policy makers, 28 there has been a lack of international comparative perspectives on service developments. 29 Differences in the amount and source of data and the difficulties of cross country comparative analysis have previously been recognised. 29 However, including the perspectives of patients and the public adds a new dimension to these complexities.
Strengths and limitations
Involving stakeholders early in project development in seven European countries was a major strength as it assisted the identification of issues that were common across countries. This provides 'added value' as it enhances the likelihood of the findings having international relevance. However, while using different methods of stakeholder involvement was a strength in terms of being locally appropriate, it proved challenging in terms of synthesis. Limitations exist in the reporting of differences in professional and lay perspectives across countries. Almost all stakeholders were White Christians which limits identification of the views of ethnic minority groups who are known to have specific palliative care needs. 30 
Conclusion
There are no gold standard approaches for stakeholder involvement across Europe. However, our findings indicate this can be done successfully in a variety of different ways, using a variety of different approaches/methods. Researchers should consider understandings about stakeholder involvement in the local context when undertaking this in more than one country as some approaches/methods may be considered more appropriate than others. Although it may not be straightforward, it is both feasible and worthwhile to invest in palliative care stakeholder consultation when undertaking research. Irrespective of the method used, the added value of international stakeholder involvement is evident. Stakeholder involvement enhanced the project team's understanding of issues in palliative care that were common across countries. Stakeholder information can inform project decision making about both the intervention and comparator used in the main HTA research question and the focus of sub questions used to assess other aspects in the project. Such widespread stakeholder involvement potentially enhances the applicability of the project findings. Methods for stakeholder involvement need further development, especially with reference to stakeholder consultation and synthesis of information from the different approaches that can be used.
